Residency · Residency · Otolaryngology

Paragangliomas of the Head and Neck

Introduction

Paragangliomas are rare, slow-growing, highly vascular neoplasms arising from paraganglia of the autonomic nervous system. In the head and neck, they most commonly arise from the carotid body, jugular bulb, middle ear (glomus tympanicum), and the vagal nerve. Although typically benign, they can cause significant morbidity through local extension and cranial nerve involvement.

Embryology and Pathophysiology

Arise from neural crest-derived paraganglion cells (chief cells). Function as chemoreceptors (carotid body) or baroreceptors. Carotid body paragangliomas are more common at high altitude due to chronic hypoxia-induced hyperplasia. Approximately 10% are familial, associated with mutations in succinate dehydrogenase (SDH) subunit genes (SDHB, SDHC, SDHD). SDHB mutations carry the highest risk of malignancy (up to 30-50%). Multicentric tumors occur in 10-20% of sporadic cases and up to 80% in familial cases.

Classification

By Location

Carotid body tumor (CBT): most common head and neck paraganglioma. Glomus jugulare: arising from the jugular bulb adventitia. Glomus tympanicum: arising from Jacobson nerve (CN IX) on the cochlear promontory. Glomus vagale: arising from the nodose ganglion of CN X.

Shamblin Classification (Carotid Body Tumors)

Type I: small, minimal attachment to vessels, easily dissected. Type II: partially encases the carotid vessels, adherent but separable. Type III: completely encases the carotid bifurcation; may require vessel sacrifice and grafting.

Fisch Classification (Glomus Jugulare/Tympanicum)

Type A: limited to the middle ear (tympanicum). Type B: limited to the tympanomastoid area. Type C: involves the infralabyrinthine compartment and carotid canal. Type D: intracranial extension.

Clinical Presentation

Carotid body tumor: painless, slowly enlarging lateral neck mass; positive Fontaine sign (mobile horizontally but not vertically). Glomus tympanicum: pulsatile tinnitus, conductive hearing loss; reddish mass behind the tympanic membrane. Glomus jugulare: pulsatile tinnitus, hearing loss, lower cranial nerve palsies (IX, X, XI, XII). Glomus vagale: neck mass with hoarseness (vocal fold paralysis). Functional paragangliomas (catecholamine-secreting) occur in <5% of head and neck cases; screen with serum/urine catecholamines and metanephrines.

Diagnostic Workup

CT with contrast: enhancing mass with characteristic "salt and pepper" appearance on MRI. MRI with gadolinium: best for soft tissue detail and intracranial extension. CT angiography or MR angiography: defines vascular anatomy and feeding vessels. Conventional angiography: both diagnostic and allows preoperative embolization. Genetic testing: recommended for all patients, especially those with multicentric or bilateral tumors, family history, or age <40. 24-hour urine catecholamines/metanephrines: rule out functional tumor before surgery.

Management

Observation

Appropriate for elderly patients, small asymptomatic tumors, or those with significant comorbidities. Average growth rate: 1-2 mm/year.

Surgery

Carotid body tumors: surgical excision is the treatment of choice; preoperative embolization 24-48 hours before surgery reduces blood loss. Glomus tympanicum: transcanal or postauricular approach for limited tumors. Glomus jugulare: infratemporal fossa approach (Fisch approach) for large tumors. Risk of cranial nerve injury increases with Shamblin type and Fisch class.

Radiation Therapy

Stereotactic radiosurgery (Gamma Knife) or fractionated radiation. Tumor control rates: 90-95%. Does not eliminate the tumor but halts growth. Preferred for elderly patients, poor surgical candidates, or residual/recurrent disease.

Key Clinical Pearls

Always obtain genetic testing in patients with head and neck paragangliomas; SDHB carriers need lifelong surveillance. Never biopsy a pulsatile middle ear mass — it may be a glomus tumor and will bleed significantly. Preoperative embolization 24-48 hours before surgery reduces intraoperative blood loss. The Fontaine sign is classic for carotid body tumors: mobile side to side but not cephalocaudally. Screen for bilateral and multicentric tumors, particularly in familial cases.

References

1. Boedeker CC, Ridder GJ, Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer. 2005;4(1):55-59.
2. Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma): clinicopathologic analysis of ninety cases. Am J Surg. 1971;122(6):732-739.
3. Neumann HP, Erlic Z, Boedeker CC, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process. Cancer Res. 2009;69(8):3650-3656.
4. Carlson ML, Sweeney AD, Pelosi S, et al. Glomus tympanicum: a review of 115 cases over 4 decades. Otolaryngol Head Neck Surg. 2015;152(1):136-142.

For the intern

At 3am, assess airway compromise first—massive paragangliomas can cause obstruction or rapid expansion after trauma. Check for acute hemorrhage if a patient had recent biopsy or intervention. Never biopsy a pulsatile middle ear mass—it will hemorrhage profusely. If a patient presents with new cranial nerve deficits (especially IX-XII), document carefully and notify your senior, but this typically represents tumor progression rather than emergency. Screen functional tumors with urine catecholamines only if surgery is planned soon; this rarely needs overnight labs. Most paragangliomas are slow-growing, so imaging and definitive management planning can wait until morning rounds.

Common pitfalls

• Performing incisional biopsy on pulsatile neck or middle ear masses—these hypervascular tumors bleed dramatically; diagnosis relies on imaging characteristics and angiography
• Forgetting genetic testing in young patients—SDH mutations drive 30-40% of head/neck paragangliomas, and SDHB carriers need lifelong surveillance for metastatic disease and extra-adrenal tumors
• Assuming all paragangliomas are benign—while most are, SDHB-mutated tumors carry 30-50% malignancy risk; always image the entire body for multicentric disease
• Missing contralateral carotid body tumors—10-20% are bilateral in sporadic cases, up to 80% in familial syndromes; bilateral neck imaging is mandatory before planning unilateral resection

Make it stick

You're seeing Mrs. Henderson, 72, who presents with a slowly growing left neck mass. She mentions it's been there for years but recently seems a bit larger. On exam, you feel a firm, rubbery mass at the carotid bifurcation that moves easily side-to-side but not up and down—a positive Fontaine sign. She denies pain, hoarseness, or difficulty swallowing. You recall the lecture on paragangliomas. Given her age and the characteristic finding, you suspect a carotid body tumor. You order imaging, specifically a CT angiogram, to assess vascular involvement, and consider whether a preoperative embolization might be beneficial if surgery proceeds. You also remember to check for urinary metanephrines, just in case.

If you remember one thing

Never biopsy a pulsatile middle ear mass or a suspicious neck mass at the carotid bifurcation without imaging, as it could be a highly vascular paraganglioma. Genetic testing is crucial, especially in younger patients or those with multiple tumors, due to hereditary links and implications for surveillance.

Read this lecture as Markdown